Pfizer Builds On AI/ML Pact With CytoReason With New Five-Year Deal

 
• By Alaric DeArment
  
Wireframe DNA sequence molecules structure mesh. Hands of robot and human touching on DNA connecting in virtual interface on future. Artificial intelligence technology concept. Vector illustration.
Pfizer and CytoReason built on their AI/ML pact with a new deal • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from AI

More from Digital Technologies